Inventor · disambiguated record
Kenneth E. Rittle
Also filed as: RITTLE KENNETH E
10 granted patents·1 pending application·355 citations·filing 1981–2010
90Inventor score
Top patents by PatentIndex Score
11 records- 0196US5756504ATocolytic oxytocin receptor antagonistsMERCK & CO INC·Filed 1995·Granted May 26, 1998·112 cites·11 claims
- 0294US5464788ATocolytic oxytocin receptor antagonistsMERCK & CO INC·Filed 1994·Granted Nov 7, 1995·135 cites·11 claims
- 0388US5670509ATocolytic oxytocin receptor antagonistsMERCK & CO INC·Filed 1993·Granted Sep 23, 1997·41 cites·11 claims
- 0488US4397786AMethod of preparing statine and derivativesMERCK & CO INC·Filed 1981·Granted Aug 9, 1983·26 cites·7 claims
- 0579US7745452B2Quinazolinone T-type calcium channel antagonistsMERCK SHARP & DOHME·Filed 2006·Granted Jun 29, 2010·4 cites·12 claims
- 0678US6387893B1Spirotricyclic substituted azacycloalkane derivatives and uses thereofMERCK & CO INC·Filed 2000·Granted May 14, 2002·13 cites·23 claims
- 0777US6515011B2Thrombin inhibitorsMERCK & CO INC·Filed 2001·Granted Feb 4, 2003·11 cites·23 claims
- 0874US8003653B2Imidazolidinone compounds useful as β-secretase inhibitors for the treatment of Alzheimer's diseaseMERCK SHARP & DOHME·Filed 2006·Granted Aug 23, 2011·4 cites·19 claims
- 0949US4609641ARenin-inhibitory peptide analogsMERCK & CO INC·Filed 1984·Granted Sep 2, 1986·9 cites·4 claims
- 1041US8114887B2Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzheimer's diseaseBARROW JAMES C·Filed 2005·Granted Feb 14, 2012·0 cites·11 claims
- 1140US2010261741A1Quinazolinone T-Type Calcium Channel AntagonistsMERCK·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kenneth E. Rittle files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →